Kalayoglu Murat bought RNAC
January 2, 2024 · Form 4 insider transaction
Kalayoglu Murat bought 178,000 shares of Cartesian Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
178,000
Price
$0.00
Total value
N/A
InsiderKalayoglu Murat
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2024
Filing dateJanuary 4, 2024
Shares owned after435,739
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in three equal annual installments so that the underlying shares will be fully vested on January 2, 2027.